Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Autologous cell therapy refers to the injection or delivery of human tissue or cells to the same person to treat pathological conditions. For the same purpose, the stem cells are taken out of the patient, harvested, cultured, and transplanted again to the same person. The purpose of this method is to reduce the chance of rejecting treatment in the body. In addition, autologous cell therapy does not require immunosuppression.
The report details the trend, potential and market size of Autologous Cell Therapy market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Autologous Cell Therapymarket, defines the market attractiveness level of Autologous Cell Therapy market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Autologous Cell Therapy industry, describes the types of Autologous Cell Therapy market, the applications of major players and the market size, and deeply analyzes the current situation of the global Autologous Cell Therapy market and the development prospects and opportunities of Autologous Cell Therapy industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Autologous Cell Therapy market in Chapter 13.
By Player:
Sumitomo Chemical Co Ltd
Holostem Terapie Avanzate Srl
Teva Pharmaceutical Industries Ltd
Brainstorm Cell Therapeutics Inc
Bayer AG
Osiris Therapeutics Inc
Takeda Pharmaceutical Co Ltd
FUJIFILM Holdings Corp
Daiichi Sankyo Co Ltd
Vericel Corp
By Type:
Bone Marrow
Epidermis
By End-User:
Cancer
Neurodegenerative Diseases
Wound Healing
Orthopedic
Cardiovascular diseases
Autoimmune Diseases
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Autologous Cell Therapy Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Autologous Cell Therapy Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Autologous Cell Therapy Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Autologous Cell Therapy Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Autologous Cell Therapy Market Analysis and Outlook to 2022
-
7.1 Global Autologous Cell Therapy Consumption (2017-2022)
-
7.2 United States Autologous Cell Therapy Consumption (2017-2022)
-
7.3 Europe Autologous Cell Therapy Consumption (2017-2022)
-
7.4 China Autologous Cell Therapy Consumption (2017-2022)
-
7.5 Japan Autologous Cell Therapy Consumption (2017-2022)
-
7.6 India Autologous Cell Therapy Consumption (2017-2022)
-
7.7 South Korea Autologous Cell Therapy Consumption (2017-2022)
8 Region and Country-wise Autologous Cell Therapy Market Analysis and Outlook to 2028
-
8.1 Global Autologous Cell Therapy Consumption Forecast (2022-2028)
-
8.2 United States Autologous Cell Therapy Consumption Forecast (2022-2028)
-
8.3 Europe Autologous Cell Therapy Consumption Forecast (2022-2028)
-
8.4 China Autologous Cell Therapy Consumption Forecast (2022-2028)
-
8.5 Japan Autologous Cell Therapy Consumption Forecast (2022-2028)
-
8.6 India Autologous Cell Therapy Consumption Forecast (2022-2028)
-
8.7 South Korea Autologous Cell Therapy Consumption Forecast (2022-2028)
9 Global Autologous Cell Therapy Market Outlook by Types and Applications to 2022
-
9.1 Global Autologous Cell Therapy Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Bone Marrow Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Epidermis Consumption and Growth Rate (2017-2022)
-
9.2 Global Autologous Cell Therapy Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Neurodegenerative Diseases Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Wound Healing Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Orthopedic Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Cardiovascular diseases Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Autoimmune Diseases Consumption and Growth Rate (2017-2022)
-
9.2.7 Global Other Consumption and Growth Rate (2017-2022)
10 Global Autologous Cell Therapy Market Outlook by Types and Applications to 2028
-
10.1 Global Autologous Cell Therapy Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Bone Marrow Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Epidermis Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Autologous Cell Therapy Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Neurodegenerative Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Wound Healing Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Orthopedic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Cardiovascular diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Autoimmune Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.7 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Autologous Cell Therapy Import and Export Analysis (Top 5 Countries)
-
11.1 Global Autologous Cell Therapy Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Autologous Cell Therapy Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Autologous Cell Therapy Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Autologous Cell Therapy Market Competitive Analysis
-
14.1 Sumitomo Chemical Co Ltd
-
14.1.1 Sumitomo Chemical Co Ltd Company Details
-
14.1.2 Sumitomo Chemical Co Ltd Autologous Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Sumitomo Chemical Co Ltd Autologous Cell Therapy Product and Service
-
14.2 Holostem Terapie Avanzate Srl
-
14.2.1 Holostem Terapie Avanzate Srl Company Details
-
14.2.2 Holostem Terapie Avanzate Srl Autologous Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Holostem Terapie Avanzate Srl Autologous Cell Therapy Product and Service
-
14.3 Teva Pharmaceutical Industries Ltd
-
14.3.1 Teva Pharmaceutical Industries Ltd Company Details
-
14.3.2 Teva Pharmaceutical Industries Ltd Autologous Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Teva Pharmaceutical Industries Ltd Autologous Cell Therapy Product and Service
-
14.4 Brainstorm Cell Therapeutics Inc
-
14.4.1 Brainstorm Cell Therapeutics Inc Company Details
-
14.4.2 Brainstorm Cell Therapeutics Inc Autologous Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Brainstorm Cell Therapeutics Inc Autologous Cell Therapy Product and Service
-
14.5 Bayer AG
-
14.5.1 Bayer AG Company Details
-
14.5.2 Bayer AG Autologous Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Bayer AG Autologous Cell Therapy Product and Service
-
14.6 Osiris Therapeutics Inc
-
14.6.1 Osiris Therapeutics Inc Company Details
-
14.6.2 Osiris Therapeutics Inc Autologous Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Osiris Therapeutics Inc Autologous Cell Therapy Product and Service
-
14.7 Takeda Pharmaceutical Co Ltd
-
14.7.1 Takeda Pharmaceutical Co Ltd Company Details
-
14.7.2 Takeda Pharmaceutical Co Ltd Autologous Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Takeda Pharmaceutical Co Ltd Autologous Cell Therapy Product and Service
-
14.8 FUJIFILM Holdings Corp
-
14.8.1 FUJIFILM Holdings Corp Company Details
-
14.8.2 FUJIFILM Holdings Corp Autologous Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 FUJIFILM Holdings Corp Autologous Cell Therapy Product and Service
-
14.9 Daiichi Sankyo Co Ltd
-
14.9.1 Daiichi Sankyo Co Ltd Company Details
-
14.9.2 Daiichi Sankyo Co Ltd Autologous Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Daiichi Sankyo Co Ltd Autologous Cell Therapy Product and Service
-
14.10 Vericel Corp
-
14.10.1 Vericel Corp Company Details
-
14.10.2 Vericel Corp Autologous Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Vericel Corp Autologous Cell Therapy Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Autologous Cell Therapy
-
Figure Autologous Cell Therapy Picture
-
Table Global Autologous Cell Therapy Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Autologous Cell Therapy Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Autologous Cell Therapy Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Autologous Cell Therapy Consumption by Country (2017-2022)
-
Figure United States Autologous Cell Therapy Consumption and Growth Rate (2017-2022)
-
Table Europe Autologous Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure China Autologous Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Japan Autologous Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure India Autologous Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure South Korea Autologous Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Autologous Cell Therapy Consumption Forecast by Country (2022-2028)
-
Figure United States Autologous Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Autologous Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Autologous Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Autologous Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Autologous Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Autologous Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bone Marrow Consumption and Growth Rate (2017-2022)
-
Figure Global Epidermis Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Neurodegenerative Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Wound Healing Consumption and Growth Rate (2017-2022)
-
Figure Global Orthopedic Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiovascular diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Autoimmune Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Bone Marrow Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Epidermis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Neurodegenerative Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Wound Healing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Orthopedic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiovascular diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Autoimmune Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Autologous Cell Therapy Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Autologous Cell Therapy Export by Region (Top 5 Countries) (2017-2028)
-
Table Sumitomo Chemical Co Ltd (Foundation Year, Company Profile and etc.)
-
Table Sumitomo Chemical Co Ltd Autologous Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sumitomo Chemical Co Ltd Autologous Cell Therapy Product and Service
-
Table Holostem Terapie Avanzate Srl (Foundation Year, Company Profile and etc.)
-
Table Holostem Terapie Avanzate Srl Autologous Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Holostem Terapie Avanzate Srl Autologous Cell Therapy Product and Service
-
Table Teva Pharmaceutical Industries Ltd (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Industries Ltd Autologous Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Industries Ltd Autologous Cell Therapy Product and Service
-
Table Brainstorm Cell Therapeutics Inc (Foundation Year, Company Profile and etc.)
-
Table Brainstorm Cell Therapeutics Inc Autologous Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Brainstorm Cell Therapeutics Inc Autologous Cell Therapy Product and Service
-
Table Bayer AG (Foundation Year, Company Profile and etc.)
-
Table Bayer AG Autologous Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer AG Autologous Cell Therapy Product and Service
-
Table Osiris Therapeutics Inc (Foundation Year, Company Profile and etc.)
-
Table Osiris Therapeutics Inc Autologous Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Osiris Therapeutics Inc Autologous Cell Therapy Product and Service
-
Table Takeda Pharmaceutical Co Ltd (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceutical Co Ltd Autologous Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceutical Co Ltd Autologous Cell Therapy Product and Service
-
Table FUJIFILM Holdings Corp (Foundation Year, Company Profile and etc.)
-
Table FUJIFILM Holdings Corp Autologous Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table FUJIFILM Holdings Corp Autologous Cell Therapy Product and Service
-
Table Daiichi Sankyo Co Ltd (Foundation Year, Company Profile and etc.)
-
Table Daiichi Sankyo Co Ltd Autologous Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Daiichi Sankyo Co Ltd Autologous Cell Therapy Product and Service
-
Table Vericel Corp (Foundation Year, Company Profile and etc.)
-
Table Vericel Corp Autologous Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vericel Corp Autologous Cell Therapy Product and Service
-
